The randomized ZIPANGU trial of ranibizumab and adjunct laser for macular edema following branch retinal vein occlusion in treatment-naïve patients

The ZIPANGU study assessed the efficacy and safety of ranibizumab as a one loading dose + pro re nata (one + PRN) regimen with/without focal/grid laser among treatment-naïve patients suffering from macular edema (ME) following branch retinal vein occlusion (BRVO). ZIPANGU was a phase IV, prospective...

Descripción completa

Detalles Bibliográficos
Autores principales: Murata, Toshinori, Kondo, Mineo, Inoue, Makoto, Nakao, Shintaro, Osaka, Rie, Shiragami, Chieko, Sogawa, Kenji, Mochizuki, Akikazu, Shiraga, Rumiko, Ohashi, Yohei, Kaneko, Takeumi, Chandrasekhar, Chikatapu, Tsujikawa, Akitaka, Kamei, Motohiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7804316/
https://www.ncbi.nlm.nih.gov/pubmed/33436683
http://dx.doi.org/10.1038/s41598-020-79051-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7804316/
https://www.ncbi.nlm.nih.gov/pubmed/33436683
http://dx.doi.org/10.1038/s41598-020-79051-1

Ejemplares similares